SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-021161
Filing Date
2024-02-27
Accepted
2024-02-27 16:15:35
Documents
114
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rgnx-20231231.htm   iXBRL 10-K 3896374
2 EX-10.9 rgnx-ex10_9.htm EX-10.9 366582
3 EX-21.1 rgnx-ex21_1.htm EX-21.1 3986
4 EX-23.1 rgnx-ex23_1.htm EX-23.1 3276
5 EX-31.1 rgnx-ex31_1.htm EX-31.1 11779
6 EX-31.2 rgnx-ex31_2.htm EX-31.2 11776
7 EX-32.1 rgnx-ex32_1.htm EX-32.1 10879
8 EX-97.1 rgnx-ex97_1.htm EX-97.1 36955
9 GRAPHIC img149531916_0.jpg GRAPHIC 352136
10 GRAPHIC img149531916_1.jpg GRAPHIC 68284
11 GRAPHIC img149531916_2.jpg GRAPHIC 259488
  Complete submission text file 0000950170-24-021161.txt   17870185

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rgnx-20231231.xsd EX-101.SCH 2062804
116 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-20231231_htm.xml XML 3292030
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37553 | Film No.: 24686937
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)